Kintara Therapeutics Inc
F:3DMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kintara Therapeutics Inc
F:3DMA
|
US |
|
Caerus Mineral Resources PLC
F:98J
|
UK |
|
C
|
Compagnie des Alpes SA
SWB:JCA
|
FR |
|
Edison Lithium Corp
F:VV0
|
CA |
|
Sure Ventures PLC
F:08F
|
UK |
|
D
|
DCC PLC
F:DCC
|
IE |
Intrinsic Value
The intrinsic value for
Kintara Therapeutics Inc (3DMA) under the Base Case is hidden
EUR.
Compared with the current market price of 6.951 EUR, the stock appears hidden
.
Do our valuations actually work? See backtest results .
3DMA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 3DMA usually does or if today's premium is unusual.
See where today’s valuation sits in 3DMA’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Kintara Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Kintara Therapeutics Inc
Earnings Waterfall
Kintara Therapeutics Inc
The intrinsic value for
Kintara Therapeutics Inc (3DMA) under the Base Case is hidden EUR.
Compared with the current market price of 6.951 EUR, the stock appears hidden.